BNP Paribas Financial Markets Sells 2,123,204 Shares of Kenvue Inc. $KVUE

BNP Paribas Financial Markets lowered its position in shares of Kenvue Inc. (NYSE:KVUE) by 48.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,284,970 shares of the company’s stock after selling 2,123,204 shares during the period. BNP Paribas Financial Markets owned about 0.12% of Kenvue worth $39,416,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in KVUE. Arrowstreet Capital Limited Partnership bought a new stake in Kenvue during the second quarter worth about $6,528,000. Jump Financial LLC lifted its stake in Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after purchasing an additional 37,170 shares during the last quarter. AXA S.A. lifted its stake in Kenvue by 21.1% during the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after purchasing an additional 8,524 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Kenvue by 219.1% during the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock worth $2,040,000 after purchasing an additional 66,930 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock worth $39,217,000 after purchasing an additional 10,885 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.59% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on KVUE shares. Citigroup dropped their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Weiss Ratings lowered Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Canaccord Genuity Group lifted their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Barclays dropped their price target on Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 14th. Finally, UBS Group dropped their price target on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $19.33.

Kenvue Trading Down 2.7%

NYSE KVUE opened at $16.86 on Thursday. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $22.87. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a 50-day moving average of $17.38 and a 200-day moving average of $17.47. The firm has a market cap of $32.37 billion, a PE ratio of 19.84, a price-to-earnings-growth ratio of 1.31 and a beta of 0.54.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. During the same quarter in the previous year, the company posted $0.24 EPS. Kenvue’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date was Wednesday, May 13th. Kenvue’s payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.